vigabatrin has been researched along with Developmental Disabilities in 15 studies
Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Early EEG findings help to identify TSC infants at risk of severe epilepsy and neurodevelopmental delay and those who may benefit from preventive treatment with vigabatrin." | 5.41 | Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes. ( Aronica, E; Benova, B; Curatolo, P; De Ridder, J; Domanska-Pakieła, D; Ferrier, CH; Feucht, M; Hertzberg, C; Jansen, AC; Jansen, FE; Jóźwiak, S; Kaczorowska-Frontczak, M; Kotulska, K; Krsek, P; Kwiatkowski, DJ; Lagae, L; Lemmens, K; Moavero, R; Nabbout, R; Riney, K; Samueli, S; Verhelle, B; Vervisch, J; Weschke, B; Wojdan, K, 2021) |
| " We retrospectively evaluated the long-term outcome of 44 infants presenting with seizures in the first 12 months who received vigabatrin, and were followed up for at least 3." | 3.77 | Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. ( Bombardieri, R; Curatolo, P; Cusmai, R; Moavero, R; Vigevano, F, 2011) |
| " The child was treated with vigabatrin at age 6 months after an abnormal electroencephalogram but before onset of seizures." | 3.73 | Autistic regression associated with seizure onset in an infant with tuberous sclerosis. ( Bolton, PF; Clarke, A; Humphrey, A; Neville, BG, 2006) |
| "Early treatment of infantile spasms seems to be important." | 2.46 | Favourable prognostic factors with infantile spasms. ( Riikonen, RS, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Moavero, R | 3 |
| Kotulska, K | 2 |
| Lagae, L | 3 |
| Benvenuto, A | 1 |
| Emberti Gialloreti, L | 1 |
| Weschke, B | 2 |
| Riney, K | 2 |
| Feucht, M | 2 |
| Krsek, P | 2 |
| Nabbout, R | 2 |
| Jansen, AC | 2 |
| Wojdan, K | 2 |
| Borkowska, J | 1 |
| Sadowski, K | 1 |
| Hertzberg, C | 2 |
| Van Schooneveld, MM | 1 |
| Samueli, S | 2 |
| Maulisovà, A | 1 |
| Aronica, E | 2 |
| Kwiatkowski, DJ | 2 |
| Jansen, FE | 2 |
| Jozwiak, S | 2 |
| Curatolo, P | 3 |
| De Ridder, J | 1 |
| Verhelle, B | 1 |
| Vervisch, J | 1 |
| Lemmens, K | 1 |
| Domanska-Pakieła, D | 1 |
| Kaczorowska-Frontczak, M | 1 |
| Ferrier, CH | 1 |
| Benova, B | 1 |
| Horvath, GA | 1 |
| Hukin, J | 1 |
| Stockler-Ipsiroglu, SG | 1 |
| Aroichane, M | 1 |
| Sun, LR | 1 |
| Bosemani, T | 1 |
| Smith-Hicks, CL | 1 |
| Karvelas, G | 1 |
| Lortie, A | 1 |
| Scantlebury, MH | 1 |
| Duy, PT | 1 |
| Cossette, P | 1 |
| Carmant, L | 1 |
| Riikonen, RS | 1 |
| Verhelst, H | 1 |
| Ceulemans, B | 1 |
| De Meirleir, L | 1 |
| Nassogne, MC | 1 |
| De Borchgrave, V | 1 |
| D'Hooghe, M | 1 |
| Foulon, M | 1 |
| Van Bogaert, P | 1 |
| Cusmai, R | 1 |
| Bombardieri, R | 1 |
| Vigevano, F | 1 |
| Ergezinger, K | 1 |
| Jeschke, R | 1 |
| Frauendienst-Egger, G | 1 |
| Korall, H | 1 |
| Gibson, KM | 3 |
| Schuster, VH | 1 |
| Humphrey, A | 1 |
| Neville, BG | 1 |
| Clarke, A | 1 |
| Bolton, PF | 1 |
| Kok, RM | 1 |
| Howells, DW | 1 |
| van den Heuvel, CC | 1 |
| Guérand, WS | 1 |
| Thompson, GN | 1 |
| Jakobs, C | 3 |
| Christensen, E | 1 |
| Fowler, B | 1 |
| Clarke, MA | 1 |
| Hammersen, G | 1 |
| Raab, K | 1 |
| Kobori, J | 1 |
| Moosa, A | 1 |
| Vollmer, B | 1 |
| Rossier, E | 1 |
| Iafolla, AK | 1 |
| Matern, D | 1 |
| Brouwer, OF | 1 |
| Finkelstein, J | 1 |
| Aksu, F | 1 |
| Weber, HP | 1 |
| Bakkeren, JA | 1 |
| Gabreels, FJ | 1 |
| Bluestone, D | 1 |
| Barron, TF | 1 |
| Beauvais, P | 1 |
| Rabier, D | 1 |
| Santos, C | 1 |
| Lehnert, W | 1 |
| Hoffmann, GF | 1 |
| Hodson, AK | 1 |
| Bottiglieri, T | 1 |
| Dooley, J | 1 |
| Gordon, K | 1 |
| Dooley, K | 1 |
| Wohlrab, G | 1 |
| Boltshauser, E | 1 |
| Schmitt, B | 1 |
2 reviews available for vigabatrin and Developmental Disabilities
| Article | Year |
|---|---|
Favourable prognostic factors with infantile spasms.
Topics: Adrenocorticotropic Hormone; Anticonvulsants; Developmental Disabilities; Electroencephalography; Hu | 2010 |
4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism.
Topics: Aldehyde Oxidoreductases; Animals; Anticonvulsants; Child; Developmental Disabilities; Disease Model | 1998 |
3 trials available for vigabatrin and Developmental Disabilities
| Article | Year |
|---|---|
Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex?
Topics: Anticonvulsants; Autism Spectrum Disorder; Child, Preschool; Developmental Disabilities; Epilepsy; F | 2020 |
Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes.
Topics: Anticonvulsants; Developmental Disabilities; Early Diagnosis; Electroencephalography; Epilepsy; Fema | 2021 |
Vigabatrin as a first-line drug in West syndrome: clinical and electroencephalographic outcome.
Topics: Adrenocorticotropic Hormone; Anticonvulsants; Cerebral Cortex; Child, Preschool; Developmental Disab | 1998 |
10 other studies available for vigabatrin and Developmental Disabilities
| Article | Year |
|---|---|
Eye Findings on Vigabatrin and Taurine Treatment in Two Patients with Succinic Semialdehyde Dehydrogenase Deficiency.
Topics: Amino Acid Metabolism, Inborn Errors; Anticonvulsants; Child; Developmental Disabilities; Electroret | 2016 |
Neuroimaging Abnormalities in a Child With Infantile Spasms on High-Dose Vigabatrin.
Topics: Developmental Disabilities; Down Syndrome; Dyskinesia, Drug-Induced; Female; GABA Agents; Humans; In | 2017 |
A retrospective study on aetiology based outcome of infantile spasms.
Topics: Anticonvulsants; Cognition Disorders; Developmental Disabilities; Electroencephalography; Female; Fo | 2009 |
Treatment and long term outcome in West syndrome: the clinical reality. A multicentre follow up study.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticonvulsants; Developmental Disabilities; F | 2010 |
Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Cognition Disorders; Developmental Disabilitie | 2011 |
Monitoring of 4-hydroxybutyric acid levels in body fluids during vigabatrin treatment in succinic semialdehyde dehydrogenase deficiency.
Topics: Aldehyde Oxidoreductases; Child; Developmental Disabilities; Enzyme Inhibitors; Female; Humans; Hydr | 2003 |
Autistic regression associated with seizure onset in an infant with tuberous sclerosis.
Topics: Anticonvulsants; Autistic Disorder; Developmental Disabilities; Epilepsy; Humans; Infant; Male; Regr | 2006 |
Stable isotope dilution analysis of GABA in CSF using simple solvent extraction and electron-capture negative-ion mass fragmentography.
Topics: Aldehyde Oxidoreductases; Anticonvulsants; Carbohydrate Metabolism, Inborn Errors; Child; Developmen | 1993 |
The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients.
Topics: Adolescent; Adult; Aldehyde Oxidoreductases; Child; Child, Preschool; Developmental Disabilities; Di | 1997 |
Falsely elevated urinary ethanolamine levels due to vigabatrin.
Topics: Anticonvulsants; Child, Preschool; Developmental Disabilities; Ethanolamine; Female; gamma-Aminobuty | 1998 |